You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》據報微醫擬下半年香港上市 目標集資10億美元
阿思達克 03-06 17:18
據《路透》引述消息人士報道,騰訊(00700.HK)有份投資的微醫(WeDoctor)將推動在香港上市,並在下周邀請投行進行推介會,公司預計估值高達100億美元。據悉,微醫希望能夠在下半年上市,但可能不包括雲端業務,目標集資最多10億美元。消息人士稱,微醫已邀請香港及中國的投行舉行視像會議,而最近從友邦保險(01299.HK)加入成為微醫新首席財務官的蔡強亦會在香港參與會議。微醫於2010年成立,目前擁有2.1億個註冊用戶,並與約3,200間醫院及36萬名醫生建立聯繫,主要在中國內地提供網上預約、診斷及處方藥物的服務。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account